AzTrials
AzTrials

Microvascular Free Flap TransferNCT06634472

Artificial Intelligence-Enabled Skin Perforator Segmentation

An observational study of Microvascular Free Flap Transfer and Fibula Flap, run by The University of Hong Kong at 1 site in Hong Kong.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Computer-assisted surgery has revolutionized reconstruction with more efficient, accurate, and predictable surgery, as reported in our previous studies. Skin perforators are vessels that travel through muscles and septa to supply the skin. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Microvascular Free Flap Transfer, Fibula Flap
What is being tested?
artificial intelligence
How many people
49 participants
Where
1 siteHong Kong
Study dates
1 Dec 2024to 31 Dec 2027
How long will I take part?
1 Day
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population will include patients with maxillary or mandibular neoplastic, inflammatory, and congenital diseases, who require immediate or secondary reconstructive surgery with osteocutaneous fibula free flap.

Who may be able to join

  • Age ≥18 years, both genders;
  • Provided signed and dated informed consent form;
  • Indicated for immediate or secondary reconstructive surgery with osteocutaneous fibula free flap.

Who cannot join

  • Patients who are pregnant;
  • Patients who have medically compromised conditions and cannot tolerate surgery;
  • Patients who are unable to receive pre-operative computed tomography angiogram scans, such as those with iodine allergy;
  • Patients who have anatomical variation preventing the safe harvest of fibula free flap.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Jane J PU, MDS contact

852-28590534

drjanepu@hku.hk

Yuxiong Su, PhD contact

852-28590534

richsu@hku.hk

Hong Kong1 site, 1 recruiting
  • The University of Hong Kong

    Hong Kong, 999077

    Jane Pu, 98024552, hkupujingya@hotmail.com

    Recruiting

Other trials in Hong Kong

About this study

Official title: Validation of An Artificial Intelligence-Enabled Skin Perforator Segmentation Tool in Computer-Assisted Osteocutaneous Fibular Free Flap Harvest: A Clinical Trial

Computer-assisted surgery has revolutionized reconstruction with more efficient, accurate, and predictable surgery, as reported in our previous studies. Skin perforators are vessels that travel through muscles and septa to supply the skin. The identification of skin perforators is crucial for a safe fibula osteocutaneous free flap harvest with computer-assisted surgery. Different methods have been proposed in the past, each of which has its own limitations.

Traditionally, skin perforators are identified with a Doppler ultrasound. Berrone et al. measured the locations with a Doppler ultrasound and imported the information back to guide virtual surgical planning. However, their study showed imprecise concordance between handheld Doppler measurements and the actual perforator locations; good correlation between the location of perforators and bone segments was identified in only four out of six cases investigated. To improve on the accuracy, computed tomography angiography was used for skin perforator identification. Battaglia et al. manually marked the perforating vessel location at the subcutaneous level and reported good correlation. However, the manual segmentation of the perforator was at the subcutaneous level only. The course of the perforators, which would be more significant for the design of computer-assisted fibula osteocutaneous free flap harvest, was not shown.

Read more

To incorporate the course of skin perforators into fibula osteocutaneous free flap virtual surgical planning, Ettinger et al. first described the technique of manual tracing from computed tomography angiography in 2018 and validated its accuracy in 2022. The median absolute difference between the computed tomography angiography and intraoperative measurements was 3 millimeters. However, reports quoted an average of 2 to 3 hours spent on tracing and modeling the course of the perforators depending on their number and anatomy; consequently, this adds a significant burden to healthcare professionals.

Recently, United Imaging Intelligence has developed an artificial intelligence-based program that offers a potential solution for accurate and efficient localization of skin perforators to be incorporated into the current virtual surgical planning workflow. The proposed study aims to validate its performance in a prospective case series. This will be the first study to investigate the use of an artificial intelligence-enabled program for fibula skin paddle perforator identification.

Read the detailed description

The aim of this single-arm clinical trial is to validate the performance of the artificial intelligence-enabled skin perforator segmentation tool (artificial intelligence tool) in computer-assisted fibula free flap harvest.

To test the predictive accuracy of the artificial intelligence tool in identifying the targeted skin perforators (primary endpoint)

  • The predictive accuracy is calculated from the number of true/false positive, true/false negative targeted perforators.
  • The secondary outcomes include the sensitivity, specificity, positive, and negative predictive values (positive predictive value and negative predictive value respectively).

Our hypothesis is that the artificial intelligence-enabled vessel segmentation tool will demonstrate a high level of accuracy in identifying the fibula skin perforators.

Plan of Investigation:

(i) Study design The current study is a single-arm single-centre clinical trial to explore the performance of an artificial intelligence-enabled skin perforator segmentation tool in computer-assisted surgery fibula free flap harvest. The study protocol shall conform to Standard Protocol Items: Recommendations for Interventional Trials and Practical Robust Implementation and Sustainability Model.

Data collection procedure A case report form has been designed to collect pre- and intra-operative research data.

Patient demographics will be collected, including age, gender, body height, weight, body mass index, diagnosis, medical history, and smoking status.

Preoperative measurements will also be obtained, including but not limited to:

  • Total fibula length
  • Number and lengths of fibula segments
  • Number of immediate dental implants
  • Number of perforators
  • Type of perforators:
  1. Septocutaneous vs musculocutaneous
  2. Targeted (to be incorporated into the virtual surgical planning and harvesting) vs accessory (other perforators)
  • Relative location of the perforators, measured as the distance from the most inferior point of the lateral malleolus to:
  1. Level of the perforator, as it crosses the posterior aspect of the fibula
  2. The point where it bifurcates from the peroneal artery
  • Time spent incorporating the skin perforator model to the original virtual surgical planning workflow.

Intraoperatively, the following information will be recorded:

  • Deviation between the locations of the skin perforators identified by the artificial intelligence tool and during the surgery
  • Need for intraoperative modifications of the plan due to the perforator identification discrepancy
  • Operator satisfaction

The primary endpoint of the predictive accuracy will be calculated according to the definition by Šimundić et al. When the skin perforator is identified by both the artificial intelligence-segmentation tool and during the surgery, it will be counted as a true positive. When the perforator is identified by the artificial intelligence-segmentation tool, but not found during the surgery it is counted as a false positive. When the perforator is seen during the surgery, but not shown by the artificial intelligence tool, it is a false negative. Finally, a true negative perforator count will be derived from those subjects, who do not exhibit a false negative perforator. The predictive accuracy is identified as the percentage of true perforators among all the perforators, and is calculated as (true positive + true negative)/(true positive+false positive+true negative+false negative)*100%.

The secondary outcomes of sensitivity, specificity, positive and negative predictive values will be calculated.

(ii) Methods

The workflow has already been set up for the previous projects. The efficiency, predictability, and accuracy of the protocol have been demonstrated in previously published articles.

For the currently proposed project, the investigators aim to incorporate the artificial intelligence tool into the current virtual surgical planning workflow and assess its performance. The complete process will be divided into three parts: 1) preoperative preparation; 2) surgery and intra-operative recording; 3) postoperative revaluation. In the preliminary study, the investigators have established the feasibility of the methodology via several pilot cases.

  1. Preoperative preparations: Preoperative computed tomography imaging: Patients enrolled in the study will receive a computed tomography scan on a General Electric revolution system (General Electric Healthcare, Chicago, IL) with slice thicknesses of 0.625 mm for both the head and neck, and lower limbs. Iodinated contrast medium (Iopamiro 370, Bracco, Israel) at a concentration of 370 mg/ml will be administered intravenously at a flow rate of 4 to 5 ml/sec, computed tomography angiogram of the lower extremity will be taken at the arterial phase. The imaging data will be exported in the Digital Imaging and Communications in Medicine format. Artificial intelligence-enabled segmentation of skin perforators from computed tomography angiogram: The Digital Imaging and Communications in Medicine data of the computed tomography angiogram will be imported to the artificial intelligence workstation (United Imaging Intelligence, Shanghai, China). The tibia and fibula bone, skin, blood vessels of the lower extremities including the anterior tibial artery, posterior tibial artery, and peroneal artery will be segmented with pre-set threshold range to generate the stereolithography (.stl) models. Based on the fully convolutional neural network of V-net, the blood vessel branches from the peroneal artery will be automatically segmented to build the .stl model. The small perforating vessels from the peroneal artery, traveling laterally, crossing the posterior edge of the fibula bone to the skin surface, will be marked as skin perforators. The .stl models of the fibula bone, skin, anterior tibial artery, posterior tibial artery, peroneal artery, and skin perforators will be exported from the workstation for incorporation into the virtual surgical planning workflow. Virtual surgery planning: Preoperative imaging and building of models Preoperative computed tomography scan will be imported to ProPlan CMF 2.1 software (Materialise, Leuven, Belgium). Volume segmentation will be performed to build the 3D virtual models of the jaws. Incorporating the skin perforators The .stl models exported from the artificial intelligence workstation will be imported to the ProPlan file. The fibula length and skin perforator location will be measured and recorded. Virtual fibula flap harvest, segmentation, and dental implant insertion Virtual surgical planning will be performed using the methodology described in the previous publications. The extent of resection will be pre-determined, based on the type and extension of the pathology. The osteotomies for fibula harvest and segmentation will be planned to suit the defect after guided tumour resection. The location of the immediate dental implants will be marked in the fibula segments. Taking the location of the skin perforators into consideration, the osteotomies can be adjusted to include the take-off point of the skin perforators, while avoiding placing the perforator directly in planned osteotomies or implant insertion points. Design and fabrication of surgical guides and/or plates After the virtual surgical planning is confirmed, the surgical guides and/or plates will be designed using 3-matic 13.0 software (Materialise, Leuven, Belgium). The location of the perforators as they cross the posterior edge of the fibula will be marked with a small sphere on the fibula harvest guide. The guides will be printed with biocompatible and autoclavable resin - either MED610 (Stratasys Ltd, Eden Prairie, MN, USA) or NextDent SG (Vertex Dental, The Netherlands).
  2. Surgical procedures and intraoperative recording All the surgical procedures will be conducted in the routine manner of computer-assisted surgery jaw reconstruction using fibula free flap by the principal applicant. Briefly, osteotomies, direct dental implant insertion, bone movements, and bone inset will be guided by the prepared surgical templates. Intraoperative measurements will be conducted. Any false positive or false negative perforators will be recorded. Any unanticipated event that requires the modification of the fibula harvest plan will be recorded. Standard perioperative management will be conducted in a routine manner.
  3. Postoperative evaluation Postoperative evaluation will be conducted between the surgical team led by the principal applicant and the computer science team led by the co-applicant. Any intraoperative events will be discussed in a timely manner. Data entry will be performed for each case right after the surgery. (iii) Sample size The calculation of the sample size is by the primary endpoint. As the success rate of the conventional method in identifying a reliable correlation was 67%, the aim of the artificial intelligence-segmentation tool is to achieve a minimum accuracy of 80%. A one-sided test for non-inferiority/superiority is employed. The sample size is calculated using the exact binomial test for a one-sample non-inferiority/superiority clinical study. The hypothesis can be unified as: H0: p = p0 + δ versus Ha: p = p1. Here, δ represents the intervention effect size; p0 equals 80% and p is the true accuracy which is hypothesised to exceed 80% with a statistical power of at least 90% with a 5% level of significance.

According to a previous report on the artificial intelligence-enabled skin perforator segmentation tool, the diagnostic accuracy was reported as 97%. The investigators can conservatively estimate the true success rate as 95% (representing an intervention effect size of 15%). Based on the calculation, a sample size of 44 is expected to have a 93.3% statistical power. Assuming at least one targeted perforator for each case and a dropout rate after signing the informed consent of 10%, a total of 49 patients will be recruited to the study.

(iv) Data processing and analysis

All the data in this protocol will be recorded using a specially designed case report form (Appendix). Discrepancies in the database will be traced to the original documents for resolution. All records will be audited 100% for accuracy. Data entry will be performed by two independent assistants using the IBM SPSS Statistics Version 25. Consistency of input data between assistants will be compared using an in-built function.

For the demographic information, data will be presented as mean values with standard deviations for continuous data, and as counts with proportions for categorical data. The predictive accuracy will be presented as a frequency. The one-sided 95% binomial proportion confidence interval will be computed, and the lower confidence limit will be compared with 80%. The sensitivity, specificity, and positive and negative predictive values will be calculated. Continuous data will be expressed as mean values with standard deviation for normally distributed data and expressed as the median with interquartile range or range for skewed data. To evaluate the effect of various confounding variables on the precision of perforators identified by artificial intelligence, suitable tests such as Pearson or Spearman's correlation test, t-Test, or Wilcoxon Signed-rank test will be selected depending on the normality of the data. Statistical significance will be set at p< 0.05. All statistical analyses will be performed using IBM SPSS Statistics Version 25.

Being tested
artificial intelligence
Keywords
skin perforator identification with artificial intelligence-segmentation tool, computer-assisted surgery, jaw reconstruction, artificial intelligence, skin perforators

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • artificial intelligenceOther

    Artificial intelligence-enabled skin perforator segmentation tool

Study groups in NCT06634472
Study groupRoleWhat they receive
Patients requiring computer-assisted jaw reconstruction with microvascular free flapsInclusion criteria 1. Age ≥18 years, both genders; 2. Provided signed and dated informed consent form; 3. Indicated for immediate or secondary reconstructive surgery with osteocutaneous fibula free flap. Exclusion criteria 1. Patients who are pregnant; 2. Patients who have medically compromised conditions and cannot tolerate surgery; 3. Patients who are unable to receive pre-operative computed tomography, computed tomography Aagiography scans, such as those with iodine allergy; 4. Patients who have anatomical variation preventing the safe harvest of fibula free flap;
Receives: Other: artificial intelligence

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. predictive accuracy of the artificial intelligence tool in identifying the targeted skin perforators

    The primary endpoint is the predictive accuracy of the artificial intelligence-enabled skin perforator segmentation tool. When the skin perforator is identified by both the AI-segmentation tool and during the surgery, it will be counted as a true positive (TP). When the perforator is identified by the AI-segmentation tool, but not found during the surgery it is counted as a false positive (FP). When the perforator is seen during the surgery, but not shown by the AI tool, it is a false negative (FN). Finally, a true negative (TN) perforator count will be derived from those subjects, who do not exhibit an FN perforator. The predictive accuracy (PA) is identified as the percentage of true perforators among all the perforators, and is calculated as (TP +TN)/(TP+FP+TN+FN)*100%.

    Measured: 36 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Oct 2024
  2. Study start1 Dec 2024
  3. Primary completion30 Sep 2027 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
49 participants (estimated)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT06634472
Sponsor's protocol ID
UW 24-354
Status last verified
Mar 2026
First submitted
2 Oct 2024
Last updated
3 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Pu JJ, Choi WS, Yang WF, Zhu WY, Su YX. Unexpected Change of Surgical Plans and Contingency Strategies in Computer-Assisted Free Flap Jaw Reconstruction: Lessons Learned From 98 Consecutive Cases. Front Oncol. 2022 Feb 4;12:746952. doi: 10.3389/fonc.2022.746952. eCollection 2022.

    PubMed 35186723
  • Powcharoen W, Yang WF, Yan Li K, Zhu W, Su YX. Computer-Assisted versus Conventional Freehand Mandibular Reconstruction with Fibula Free Flap: A Systematic Review and Meta-Analysis. Plast Reconstr Surg. 2019 Dec;144(6):1417-1428. doi: 10.1097/PRS.0000000000006261.

    PubMed 31764662
  • Pu JJ, Choi WS, Yu P, Wong MCM, Lo AWI, Su YX. Do predetermined surgical margins compromise oncological safety in computer-assisted head and neck reconstruction? Oral Oncol. 2020 Dec;111:104914. doi: 10.1016/j.oraloncology.2020.104914. Epub 2020 Jul 23.

    PubMed 32712577
  • Pu JJ, Lo AWI, Wong MCM, Choi WS, Ho G, Yang WF, Su YX. A quantitative comparison of bone resection margin distances in virtual surgical planning versus histopathology: a prospective study. Int J Surg. 2024 Jan 1;110(1):111-118. doi: 10.1097/JS9.0000000000000780.

    PubMed 37737999
  • Pu JJ, Hakim SG, Melville JC, Su YX. Current Trends in the Reconstruction and Rehabilitation of Jaw following Ablative Surgery. Cancers (Basel). 2022 Jul 7;14(14):3308. doi: 10.3390/cancers14143308.

    PubMed 35884369
  • Su YR, Ganry L, Ozturk C, Lohman R, Al Afif A, McSpadden R, Frias V, Pu JJ. Fibula Flap Reconstruction for the Mandible: Why It Is Still the Workhorse? Atlas Oral Maxillofac Surg Clin North Am. 2023 Sep;31(2):121-127. doi: 10.1016/j.cxom.2023.04.005. No abstract available.

    PubMed 37500195

Questions about this trial

What is this clinical trial studying?

An observational study of Microvascular Free Flap Transfer and Fibula Flap, run by The University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 3 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jane J PU, MDS (852-28590534, drjanepu@hku.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

predictive accuracy of the artificial intelligence tool in identifying the targeted skin perforators (time frame: 36 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06634472, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Mar 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in